Pharmaceutical preparations for gene therapy and gene editing; Pharmaceutical and biological preparations based on base editing, base modification, nucleobase editing, nucleobase modification, nucleic acid editing, gene editing, gene modification, gene modulation, gene therapy, genome editing, genome modification, cell therapy, cellular modification, and tissue modification for use in human therapeutics for the treatment of Myelodysplastic syndromes

Testing, inspection, research, and development of pharmaceutical preparations for gene therapy and gene editing; medical and scientific research in the fields of gene therapy and gene editing; pharmaceutical research services; pharmaceutical drug development services; Scientific and medical research in the fields of base editing, base modification, base repair, nucleobase editing, nucleobase modification, nucleobase repair, nucleic acid editing, gene editing, gene modification, gene modulation, gene reprogramming, genome editing, genome modification, cellular modification, tissue modification, organ modification; providing scientific and medical research information, and bioinformatic algorithms and models in the fields of base editing, base modification, base repair, nucleobase editing, nucleobase modification, nucleobase repair, nucleic acid editing, gene editing, gene modification, gene modulation, gene reprogramming, genome editing, genome modification, cellular modification, tissue modification, organ modification; scientific study and research in the fields of base editing, base modification, base repair, nucleobase editing, nucleobase modification, nucleobase repair, nucleic acid editing, gene editing, gene modification, gene modulation, gene reprogramming, genome editing, genome modification, cellular modification, tissue modification, organ modification to develop human pharmaceutical and biological preparations